English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Many epidemiological studies have investigated association of  AXIN2  variants on overall cancer risks; however, the available results remain inconsistent.    Methods  An updated analysis was conducted to ascertain a more accurate estimation of the correlation between  AXIN2  148 C/T, 1365 C/T, and rs4791171 A/G polymorphisms and cancer risk. We also used in silico tools to assess the effect of  AXIN2  expression on cancer susceptibility and overall survival time.    Results  A total of 4281 cases and 3955 control participants were studied. The overall results indicated that  AXIN2  148 C/T variant was associated with cancer risk (allelic contrast: OR = 0.88, 95% CI 0.77–0.99,  P  heterogeneity  = 0.004; dominant model: OR = 0.82, 95% CI 0.69–0.96,  P  heterogeneity  = 0.022), especially for lung and prostate adenocarcinoma. Similar results were observed in 1365 C/T polymorphism (OR = 0.71, 95% CI 0.61–0.98,  P  heterogeneity  = 0.873; dominant model: OR = 0.66, 95% CI 0.47–0.94,  P  heterogeneity  = 0.775). Moreover, in subgroup analysis by ethnicity, similar findings were obtained for Asian and Caucasian populations. Results from in silico tools suggested that  AXIN2  expressions in lung adenocarcinoma were lower than that in normal group.    Conclusions  Our findings indicated that  AXIN2  148 C/T and 1365 C/T variants may be associated with decreased cancer susceptibility.

New insights into the association between AXIN2 148 C/T, 1365 C/T, and rs4791171 A/G variants and cancer risk